Company
Turn Therapeutics Inc. (TTRX)
Standardized SEC financial data for Turn Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0002023016 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-68.2%
Free cash flow
-$2.6M
Current ratio
0.87×
EPS (diluted)
$-0.12
Income statement
| USD | FY2024 | FY2025 |
|---|---|---|
| R&D expense | $246K | $266K |
| SG&A expense | $1.6M | $5.6M |
| Operating income | -$1.8M | -$5.9M |
| EBITDA | -$1.7M |
Balance sheet
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $1.2M | $873K | $5.1M |
| Total current assets | — | $1.1M | $5.2M |
| Total assets | — | $2.0M |
Get TTRX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TTRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TTRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"